We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · November 29, 2022

Outcomes of Nogapendekin Alfa Inbakicept Plus BCG in Patients With BCG-Unresponsive NMIBC

NEJM Evidence


Additional Info

NEJM Evidence
IL-15 Superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer
NEJM Evid 2022 Nov 10;[EPub Ahead of Print], K Chamie, SS Chang, E Kramolowsky, et al

Further Reading